Precision Medicine in Oncology® | Specialty

The OncLive Precision Medicine in Oncology® condition center page is a comprehensive resource for clinical news and expert insights on precision-focused approaches in patients with cancer, with gene-targeted tyrosine kinase inhibitors and antibody-drug conjugates, checkpoint inhibitors, tumor-infiltrating lymphocyte therapy, and other tailored treatments. This page features news articles, interviews in written and video format, and podcasts that focus on updates and ongoing research with personalized therapies across solid and hematologic tumors.

Clinical Trial Reports: November 2007

June 29th 2010

The Clinical Trials Reported in this issue include: PHASE III: 1) Trastuzumab and Anastrozole Extend Breast Cancer Survival in Patients Who Received Anastrozole Alone Earlier PHASE II: 1) Motexafin for Non%u2013Small Cell Lung Cancer 2) Oral Satraplatin Monotherapy for the Treatment of Metastatic Breast Cancer Shows Little Response, and more

Clinical Trial Reports: May 25, 2010

May 25th 2010

Clinical trials covered include: 1) Phase III: Quality of Life with Sunitinib or Interferon Alfa for Patients with Metastatic Renal Cell Carcinoma 2) Phase II: Children%u2019s Oncology Group Pilot Study, and more

Opportunities and Challenges: A Time to Reflect at the End of a Busy Year

December 29th 2008

It is the final month of what has been economically a very tough year. Oncology centers and practices continue to face declining reimbursements on all service lines, and most have had either flat or lower revenues.

One Last Look back: The 10 Biggest Health IT Stories of 2008

December 17th 2008

Some of the Top Health IT Stories from 2008 are discussed.

The Inner Frontier: Exploring the Brave New World of Personalized Medicine

February 13th 2008

Currently available pharmaceutical therapies for many chronic illnesses leave much to be desired.